High Net Worth Advisory Group’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,500	Closed	-$6K	–	691
2022 Q2	$6K	Hold	3,500	–	–	﹤0.01%	568
2022 Q1	$9K	Buy	+3,500	New	+$9K	﹤0.01%	540